Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor

被引:120
|
作者
Sotiropoulos, A
Moutoussamy, S
Renaudie, F
Clauss, N
Kayser, C
Gouilleux, F
Kelly, PA
Finidori, J
机构
[1] UNIV PARIS 05, INSERM U344, F-75730 PARIS 15, FRANCE
[2] HOP COCHIN, INSERM U363, F-75730 PARIS 14, FRANCE
关键词
D O I
10.1210/me.10.8.998
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The GH receptor (GHR) is a member of the cytokine receptor superfamily; its signaling involves the activation of Janus tyrosine kinases (JAK2) and Stat (signal transducers and activators of transcription) transcription factors, Using truncated and tyrosine mutants of the receptor, we show that different receptor domains are essential for the activation of Stat3 and State. GH-dependent phosphorylation of JAK2, Stat3, and State, as well as transactivation studies with reporter genes containing Stat3 and State DNA-binding elements, was performed in cells expressing the various GHR mutants. The membrane-proximal region of the receptor necessary for JAK2 activation is sufficient for Stat3 activation. In contrast, C-terminal tyrosine residues of GHR are absolutely required for State activation. The same residues are also involved in the regulation of JAK2 dephosphorylation, possibly through the activation of a phosphatase. Using in vitro experiments with glutathione-S-transferase-fusion proteins, we demonstrate that the SH2 domain of Stat5 binds to the carboxy-terminal tyrosine-phosphorylated residues of GHR. Our results show that a cytokine receptor can mediate differently the activation of distinct Stat proteins that could be involved in cytokine-specific effects.
引用
收藏
页码:998 / 1009
页数:12
相关论文
共 50 条
  • [31] The Status of STAT3 and STAT5 in Human Breast Atypical Ductal Hyperplasia
    Shi, Aiping
    Dong, Jie
    Hilsenbeck, Susan
    Bi, Lirong
    Zhang, Hong
    Li, Yi
    [J]. PLOS ONE, 2015, 10 (07):
  • [32] STAT3 and STAT5 regulations in gallic Acid & quercetin treated cells
    Gul, Huseyin
    Zergeroglu, Asuman Demiroglu
    [J]. ANTI-CANCER DRUGS, 2015, 26 : E27 - E27
  • [33] Glucocorticoid receptor/signal transducer and activator of transcription 5 (STAT5) interactions enhance STAT5 activation by prolonging STAT5 DNA binding and tyrosine phosphorylation
    Wyszomierski, SL
    Yeh, J
    Rosen, JM
    [J]. MOLECULAR ENDOCRINOLOGY, 1999, 13 (02) : 330 - 343
  • [34] Patterns of constitutive activation of signal transducers and activators of transcription 3 and 5 (STAT3 and STAT5) in primary CNS lymphomas (PCNSL)
    Iorga, P
    Owor, G
    Nazeer, T
    Yang, XH
    Sheehan, CE
    Ross, JS
    Qian, J
    [J]. LABORATORY INVESTIGATION, 2005, 85 : 292A - 292A
  • [35] Suppressor of cytokine signaling 7 inhibits prolactin, growth hormone, and leptin signaling by interacting with STAT5 or STAT3 and attenuating their nuclear translocation
    Martens, N
    Uzan, G
    Wery, M
    Hooghe, R
    Hooghe-Peters, EL
    Gertler, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (14) : 13817 - 13823
  • [36] Patterns of constitutive activation of signal transducers and activators of transcription 3 and 5 (STAT3 and STAT5) in primary CNS lymphomas (PCNSL)
    Iorga, P
    Owor, G
    Nazeer, T
    Yang, XH
    Sheehan, CE
    Ross, JS
    Qian, J
    [J]. MODERN PATHOLOGY, 2005, 18 : 292A - 292A
  • [37] Expressional STAT3/STAT5 Ratio is an Independent Prognostic Marker in Colon Carcinoma
    Klupp, Fee
    Diers, Johannes
    Kahlert, Christoph
    Neumann, Lena
    Halama, Niels
    Franz, Clemens
    Schmidt, Thomas
    Lasitschka, Felix
    Warth, Arne
    Weitz, Juergen
    Koch, Moritz
    Schneider, Martin
    Ulrich, Alexis
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S1548 - S1555
  • [38] Structural Implications of STAT3 and STAT5 SH2 Domain Mutations
    de Araujo, Elvin D.
    Orlova, Anna
    Neubauer, Heidi A.
    Bajusz, David
    Seo, Hyuk-Soo
    Dhe-Paganon, Sirano
    Keseru, Gyorgy M.
    Moriggl, Richard
    Gunning, Patrick T.
    [J]. CANCERS, 2019, 11 (11)
  • [39] Expressional STAT3/STAT5 Ratio is an Independent Prognostic Marker in Colon Carcinoma
    Fee Klupp
    Johannes Diers
    Christoph Kahlert
    Lena Neumann
    Niels Halama
    Clemens Franz
    Thomas Schmidt
    Felix Lasitschka
    Arne Warth
    Juergen Weitz
    Moritz Koch
    Martin Schneider
    Alexis Ulrich
    [J]. Annals of Surgical Oncology, 2015, 22 : 1548 - 1555
  • [40] Expression of STAT3 and STAT5 in non-small cell lung cancers
    Patel, RA
    Owor, G
    Sheehan, CE
    Ross, JS
    Jennings, TA
    [J]. MODERN PATHOLOGY, 2005, 18 : 316A - 316A